Topic table - Longitudinal Aging Study Amsterdam

Topic Table - overview

LASA has data available on many different topics in various functional domains. To make it easier for those who would like to make use of LASA data, the topic table below provides an overview of the topics for which data are available in LASA, the corresponding data file number, and the measurement cycles (waves) in which the topic is included. When clicking on the topic name, you will be re-directed to a page with more detailed documentation on the specific topic. This table is a concatenation of all theme tables which can be shown by clicking on the menu-items behind “themes”.

Legend

UC: Under Construction

*: in wave C, the same interview was administered to both respondents and proxies (processed in LASA6xx-files)

**: not yet documented

Note I: some of the data are not yet available (in red)

Note II: the table is also horizontally scrollable. So, if e.g. the last column does not show, it can be made visible by sliding the horizontal scroll bar at the bottom of the table forwards. In the desktop version you can also click on an empty space in the table and use the right and left keys on the key board to move the table backwards and forwards

Note III: investigations for the K-wave will take place in 2021-2022. Results for this wave will be made available in the course of 2022 or later.

LASA-WAVE	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Cohort 1
Cohort 2
Cohort 3
Migrant Cohort

THEME BIOMATERIAL
Blood collection and overview (routine) measurements – Response blood sampling / DNA Date blood sampling	850 851	850 851	– –	– –	851	– –	850 851	– –	850 851	– –	– –	– –	– –
Routine measurements (Albumin and cholesterol)	860	860	–	–	860	–	860	–	860	–	–	–	–
Adiponectin, leptin and ghrelin	–	–	–	–	–	–	879	–	–	–	–	–	–
Apolipoprotein E (ApoE) – Phenotyping – Genotyping	870 –	– –	– –	– –	870 –	– –	–	– –	– –	– –	– –	– –	– –
Cholesterol, triglycerides and fructosamin	–	867	–	–	–	–	–	–	–	–	–	–	–
COLIA1 (Collagen type I α1 Sp1 polymorphism in LASA)	–	871	–	–	–	–	–	–	–	–	–	–	–
Cortisol (total plasma cortisol, corticosteroid binding globuline, salivary cortisol) – Serum cortisol – Salivary cortisol	– –	864 –	– –	– 880/ 881/ 882	– –	– –	– –	– –	– –	– –	– –	– –	– –
	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Hair cortisol (LASA ancillary study)
Genetic polymorphisms (VDR, GR, etc) – Vit D Receptors – Haplotypes	– –	872 873	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –
GWAS data	–	X	–	–	X	–	X	–	X	–	–	–	–
Exome Chip	–	X	–	–	–	–	X	–	–	–	–	–	–
Homocysteine, vitamin B12, MMA	–	866	–	–	–	–	–	–	–	–	–	–	–
Bone-related hormones and bone turnover	–	862	–	–	–	–	–	–	–	–	–	–	–
Inflammation factors – Pro-inflammatory cytokine Interleukin-6 (IL-6) – Acute-phase proteins C-reactive protein (CRP) – A1- antichymotrypsin (ACT)	861	861	–	–	–	–	–	–	861	–	–	–	–
Serum Amyloid P component (SAP)	–	868	–	–	–	–	–	–	–	–	–	–	–
Serum 25-hydroxy- vitamin D (25(OH)D) and parathyroid hormone (PTH)	–	862	–	–	862	–	862	–	862	–	–	–	–
Sex hormones	–	863	–	–	–	–	–	–	–	–	–	–	–
Thyroid function	–	865	–	–	–	–	–	–	–	–	–	–	–
Vitamin K status	–	–	–	–	869	–	–	–	–	–	–	–	–

THEME CARE
Attitudes about care	032 112 –	– – –	– – –	– – –	– 112 –	– 112 –	– 112 –	– 112 –	– 112 –	– 112 –	– 112 –	– 112 175	– 112 175
Filial responsibility expectations ^IM – scaled	– –	– –	132 332	132 332	– –	– –	– –	– –	– –	– –	– –	132 332	– –
Vignettes about help – total scores	– –	– –	074 274	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –

Providing care	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Providing assistance with personal/ household care	–	–	–	–	142	142	142	142	142	142	142	142	142
Family caregiving to older adults (LASA ancillary study)				X

Use of care	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Use of personal/ household care -tel.proxy* -tel.respondent*	033 – –	033 603 603	033 603 703	033 603 703	033 – –	033 603 703	033 603 703	033 603 703	033 – –	033 – –	033 603 703	033 603 703	033
Care evaluation	033	033	033	033	033	033	033	033	033	033	033	033	033
Use of nursing care -tel. proxy* -tel. respondent*	– – –	– – –	– – –	– – –	– – –	– – –	– – –	033 603 703	033 – –	033 – –	033 603 703	033 603 703	033
Use of transport/ admin. care -tel.proxy* -tel.respondent*	– – –	– – –	– – –	– – –	– – –	– – –	– – –	033 603 703	– – –	– – –	033 603 703	033 603 703	033
Personal budget (PGB)	–	–	–	–	–	–	–	033	–	–	–	–	–
Perceived control of care	–	–	–	–	–	–	–	033	033	033	033	033	033
Satisfaction with care	033	033	033	033	033	033	033	033	033	033	033	033	033
Need for care	–	–	–	–	–	033	033	033	033	033	033	033	033
Aggr. variables care network	–	–	–	–	–	–	–	233	–	–	–	–	–
Use of respite care by R (for partner)	–	–	–	–	–	–	–	–	–	–	139	139	139
Perceived control in health care and scale (LASA ancillary study)								X
Transitions in care** (LASA ancillary study)

Adaptations and facilities	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Adaptations in the house (see Theme SOC)
Use of assistive devices or assistence (see Theme PHY)

Contact with services	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Contact with health and social services	044	044	044	044	044	044	044	044	044	044	044	044	044
Hospital admission -tel.proxy* -tel.respondent*	045 – –	045 603 603	045 603 703	045 603 703	045 – –	045 603 703	045 603 703	045 603 703	045 – –	045 – –	045 603 703	045 603 703	045
Outpatient contact with med. specialists last 6 months – specification of specialist	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245	045 245
Health care in country of origin	–	–	–	–	–	–	–	–	–	068	–	–	–

Needs assessment	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Needs assessment (WVG/Wmo/ AWBZ/Zvw/ Wlz)^IM -tel.proxy* -tel.proxy* -tel.respondent* -tel.respondent*	– – – – – – –	– – – – – – –	– – – – – – –	– – 189 – – – –	– – – – – – –	– – 189 610 – 710 –	177 178 189 – 611 – 711	177 178 189 – 611 – 711	– – – – – – –	– – – – – – –	177 178 189 – 611 710 711	177 178 189 610 611 710 711	177 178 189
Residential care after attrition**

End of life care and preferences	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Advance Directives -tel.respondent*	– – –	– – –	093 – 709	– – –	– – –	– 195 –	– 195 –	– 195 –	– – –	– – –	– 195 –	– 195 –	– 195 –
Feelings and wishes about life and death	–	–	–	–	–	–	–	–	–	–	127	127	127
Decisions in eol situations	–	–	–	–	–	–	148	–	–	–	–	–	–
General eol goals (see also Subj. life exp.)	–	–	–	–	–	–	094	094	094	–	094	094	094
Last wishes	–	–	–	–	–	146	–	–	–	–	–	–	–
Advance Care Planning (ACP)	–	–	–	–	–	–	–	–	–	–	108	–	–
Opinions about euthanasia and end-of-life (eol) pill	122	122	122	122	122	122	122	122	122	–	122	122	122
End-of-life care: interviews with proxies (LASA ancillary study)				X			X

THEME COGNITIVE
Intelligence and cognition	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Crystallized intelligence (GIT ©) – total scores	– –	037 237	– –	– –	– –	037 237	– –	– –	– –	– –	037 237	– –	– –
Fluid intelligence (RAVEN) – scaled Evaluation RAVEN	022 222 024	022 222 –	022 222 –	022 222 –	022 222 –	022 222 –	022 222 –	– – –	– – –	– – –	– – –	– – –	– – –
Head trauma – tel. proxy* – tel. respondent*	– – –	– – –	035 602 702	035 602 702	– – –	035 602 702	035 602 702	035 602 702	– – –	– – –	035 602 702	035 602 702	035
Information processing speed (Coding task)	155	155	155	155	155	155	155	155	155	–	155	155	155
Mini-Mental State Examination (MMSE) – MMSE scaled – MMSE subtraction/ spelling – tel. respondent* – tel. respondent: scaled	021 221 421 – –	021 221 421 – –	021 221 421 707 907	021 221 421 707 907	021 221 421 – –	021 221 421 707 907	021 221 421 707 907	021 221 421 707 907	021 221 421 – –	021 221 421 – –	021 221 421 707 907	021 221 421 707 907	021 221 421
Informant Quest. of cogn. decline (IQCODE) – tel. proxy*	–	607	607	607	–	607	607	607	–	–	607	607

Executive functioning	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Verbal fluency	–	–	–	–	–	–	–	165	165	165	165	165	165
Executive functioning (Digit span)	–	–	–	–	–	–	–	166	020	–	166	166	166

Memory	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Everyday memory	023	–	–	–	–	023	–	–	–	–	–	–	–
Episodic memory (15WT) – constructed	156 356	156 356	156 356	156 356	156 356	156 356	156 356	156 356	156 356	– –	156 356	156 356	156 356
Memory complaints	021	021	021	021	021	021	021	021	021	021	021	021	021
Metamemory – scaled	124 324	124 324	124 324	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –
Memory partner	–	–	–	139	–	139	139	139	139	–	139	139	139

Dementia	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Dementia (probable)	X	X	X	X	X	X	X	X	–	–	–	–	–
Dementia parents – tel. respondent*	– –	– –	092 708	– –	092 –	– –	– –	– –	– –	– –	– –	– –	– –
Dementia partner	–	–	–	139	–	139	139	139	139	–	139	139	139


THEME DEMOGRAPHIC
General variables	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
(Non-)response* more detailed non-response*	z002 002	z002 002	z002 002	z002 002	z002 002	z002 002	z002 002	z002 002	z002 002	– 002	z002 002	z002 002	z002 002
Age at interview*	z008	z008	z008	z008	z008	z008	z008	z008	z008	mb008	z008	z008	z008
Time of measurement*	z008	z008	z008	z008	z008	z008	z008	z008	z008	mb008	z008	z008	z008
Sex*¹	z004	–	–	–	z004	–	–	–	z004	mb004	–	–	–
Education¹	z004	–	–	–	z004	–	–	–	z004	mb004	–	–	–
Nationality*¹	z004	–	–	–	z004	–	–	–	z004	mb004	–	–	–
Ethnicity*¹	z004	–	–	–	z004	–	–	–	z004	mb004	–	–	–
Weight factors⁵

Mortality	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Mortality data	z990	z990	z990	z990	z990	z990	z990	z990	z990	–	z990	z990	z990
Mortality and cause of death – Specified	z991 z992	z991 z992	z991 z992	z991 z992	z991 z992	z991 z992	z991 z992	z991 z992	z991 z992	– –	z991 z992	z991 z992	z991 z992

Geography	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Urbanization²	z095	z095	z095	z095	z095	z095	z095	z095	z095	mb095	z095	z095	z095
History of domestic addresses*	z052	z052	z052	z052	z052	z052	z052	z052	z052	–	z052	z052	z052

Living arrangements	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Household composition*^IM	011	011	011	011	011	011	011	011	011	011	011	011	011
Housing characteristics^IM see Theme Social
Marital and partner status	z010 – –	z010 601 601	z010 601 701	z010 601 701	z010 – –	z010 601 701	z010 601 701	z010 601 701	z010 – –	mb010 – –	z010 601 701	z010 601 701	z010

Religion³	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Church affiliation	–	z038	z038	z038	z038	–	–	–	z038	038	–	–	–
Church attendance	–	–	z038	z038	z038	z038	z038	z038	z038	038	z038	038	038

Socio-economic status	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Occupation⁴	016	016	016	016	016	016	016	016	016	016	016	016	016
Income – Income specification	017 217	017 –	017 –	017 –	017 –	017 –	017 –	017 –	017 –	017 –	017 –	017	017
Income decline / evaluation	019	019	019	019	019	019	019	019	019	019	019	019	019
Health insurance*	018	–	–	–	–	–	–	–	–	–	–	–	–

THEME EMOTIONAL
ADHD	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
ADHD (LASA ancillary study) – constructed	– –	– –	– –	– –	– –	– –	179 379	– –	– –	– –	– –	– –	– –

Anxiety	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Anxiety symptoms^IM – scaled	026 226	026 226	026 226	026 226	– –	026 226	026 226	026 226	026 226	026 226	026 226	026 226	026 226
Anxiety diagnoses	X	–	X	X	X	–	X	X	–	–	X	X
Posttraumatic stress (PTSD) – scaled	– –	– –	091 291	091 291	– –	– –	– –	– –	– –	– –	– –	– –	– –

Depression	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Depressive symptoms – scaled – tel. proxy* – tel. respondent* – tel. respondent: scaled	025 225 – – –	025 225 606 606 –	025 225 606 706 906	025 225 606 706 906	025 225 – – –	025 225 – 706 906	025 225 – 706 906	025 225 – 706 906	025 225 – – –	025 225 – – –	025 225 – 706 906	025 225 – 706 906	025 225
Depression diagnoses	X	X	X	X	X	X	X	X	X	–	X	X
Depressive symptoms and food-related behaviour (LASA ancillary study)
Mental health problems and food-related behaviour (LASA ancillary study)

Evaluation of life	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Important aspects of life	110	110	110	110	110	110	110	110	110	–	110	110	110
Satisfaction with life and happiness – ‘happiness-line’	110 –	110 –	110 094	110 –	110 –	110 –	110 –	110 –	110 –	– –	110 –	110 –	110 > –
Valuation of life – scaled	– –	– –	– –	137 337	– –	137 337	– –	– –	– –	– –	– –	– –	–
Generativity	–	–	–	–	–	–	–	–	–	–	–	802	802

Personality traits	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Self-esteem – scaled	027 –	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	– –	027 227	027 227	027 227
Mastery – scaled	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227	027 227
Perceived self-efficacy – scaled	028 228	028 228	028 228	028 228	028 228	028 228	028 228	028 228	028 228	– –	028 228	028 228	027 227
Neuroticism and social inadequacy – scaled	123 323	123 323	123 323	123 323	123 323	– –	– –	– –	123 323	– –	– –	– –	– –
Meta-emotion	029	–	–	–	143^†	–	–	–	–	–	–	–	–
Humor – scaled	111 311	– –	111 311	– –	– –	– –	– –	– –	– –	– –	– –	– –	–
General self- regulation (GSR) – scaled	– –	– –	– –	– –	– –	– –	149 349	149 349	– –	– –	– –	– –	– –

(In)dependence	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Investment in independence	–	–	–	–	–	144	144	144	–	–	144	144	144

Singing and music	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Singing and making music	–	–	–	–	–	–	–	103	–	–	103	103	–

Religiousness¹	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Gerotranscendence (Cosmic transcendence) – scaled	– –	038 238	038 238	038 238	038 238	038 238	– –	– –	– –	– –	– –	– –	– –
Orthodoxy – scaled – scaled	– – – –	038 238 – –	038 – – –	038 – 138 338	038 – – –	038 – – –	038 – – –	038 – – –	038 – – –	– – – –	038 – – –	038 – – –	038 – – –
Praying	–	038	038	038	038	038	038	038	038	–	038	038	038
Salience of religion – scaled – tel. respondent*	110 – – –	110 038 238 608	110 038 238 –	110 038 238 –	110 038 238 –	110 – – –	110 – – –	110 – – –	110 – – –	– – – –	110 – – –	110 – – –	110
Religious coping	–	–	–	–	–	–	–	–	105	105	–	–	–

Sexuality	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Sexuality	120	–	–	120	120	120	–	–	120	–	–	–	–
Gender identity**	–	–	–	–	–	–	–	–	–	–	–	804	804

Sleep	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Sleep quality – scaled	117 317	117 317	117 317	117 317	117 317	117 317	117 317	117 317	117 317	– –	117 317	117 317	117

Stress and stressors	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Negative life events^IM	–	272	272	272	–	272	272	272	–	–	272	272	272
Perceived stress – scaled	– –	– –	– –	– –	– –	– –	– –	104 304	104 304	– –	– –	– –	– –

Subjective age	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Subjective life expectancy/ subj. age	–	–	094	094	–	094	094	094	–	–	094	094	094
Attitude toward ageing	071	–	–	–	–	–	–	–	–	–	–	–	–
Age norms	070	070	070	–	070	070	070	070	070	–	070	070	070

Worrying	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Worrying – scaled	– –	– –	– –	136 336	– –	– –	– –	– –	– –	– –	– –	– –	– –

THEME SOCIAL
Affiliation	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Need for affiliation – Scaled	078 – 278	– – –	– – –	078 – 278	– 141 341	– – –	– 141 341	– – –	– – –	– – –	– – –	– – –	– – –

Housing	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Housing characteristics Adaptations in the house	014 015 – – 014	014 015 601 601 014	014 015 601 701 014	014 015 601 701 014	014 015 – – 014	014 015 601 701 014	014 015 601 701 014	014 015 601 701 014	014 015 – – 014	014 015 – – –	014 015 601 701 014	014 015 601 701 014	014 015 014
Relocation -tel. proxy* -tel. respondent*	014 015 – –	014 015 601 601	014 015 601 701	014 015 601 701	014 015 – –	014 015 601 701	014 015 601 701	014 015 601 701	014 015 – –	– – – –	014 015 601 701	014 015 601 701	014 015
Neighborhood characteristics	015 z095	015 z095	015 z095	015 z095	015 z095	015 z095	015 z095	015 z095	015 z095	– z095	015 z095	015 z095	015 z095
Pets in household**	012	012	012	012	012	012	012	012	012	–	012	012	012
Residence in 1944**	013	–	–	–	–	–	–	–	–	–	–	–	–

Partner relationship	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Relationship quality	–	–	–	139	–	139	139	139	139	–	139	139	139

Relationships between generations	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Parental data**	–	–	–	–	140	–	–	–	140	–	–	–	–
Children**	048 –	048 –	– –	048 248	048 248	048 248	048 –	– –	048 248	048 248	048 –	– –	– –
Filial responsibility expectations ^IM – scaled	– –	– –	132 332	132 332	– –	– –	– –	– –	– –	– –	– –	132 332	– –
Vignettes about help –total scores	– –	– –	074 274	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –
Grandchildren**	–	–	–	–	–	049	–	–	–	–	–	–	–

Social network	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Personal network – network size	047 247	047 247	047 247	047 247	047 247	047 247	047 247	047 247 –	047 247	– –	047 247	047 247
Contact network	–	–	–	–	–	–	–	–	167	167	167	–	–

Loneliness	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Loneliness -scaled -tel. respondent* Existental loneliness	073 273 – –	073 273 – –	073 273 – –	073 273 – –	073 273 – –	073 273 – –	073 273 – –	073 273 712 –	073 273 – –	073 273 – –	073 273 712 –	073 273 712 173	073 273 173

Social participation	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Social participation	070 125	070 125	070 125	070 125	070 125	070 125	070 125	070 –	070 –	070 –	070 –	070 –	070 –
Environmental influence**	121	121	121	–	–	–	–	–	–	–	–	–	–

Social norms	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Values and norms**	122	122	122	122	122	122	122	122	122	–	122	122	122
Social desirability** – scaled	– –	130 330	– –	– –	– –	130 330	– –	– –	– –	– –	– –	– –	– –
Social identity** – scaled	– –	– –	131 331	131 331	– –	– –	– –	– –	– –	– –	– –	– –	– –
Donorship**	–	–	–	–	–	–	–	–	–	–	128	128	–
Ties with country of origin**	–	–	–	–	–	–	–	–	–	069	–	–	–

THEME WORK
Work and Retirement characteristics
Work and Retirement – tel. respondent*	016 –	016 –	016 –	016 –	016 –	016 –	016 –	016 –	016 –	016 –	016 713	016 713
Physical and psychosocial General Population Job Exposure Matrix (GPJEM)	016	016	016	016	016	016	016	016	016	016	016	016
Work Perception	–	–	–	–	–	–	–	–	106	106	106	106

THEME PHYSICAL
Blood pressure	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Blood pressure/ pulse – retests	151 –	151 –	151 –	151 –	151 151	151 –	151 151	151 151	151 151	151 –	151 151	151 151

Body composition	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Anthropometry – Weight and height – Calf measurement – Ankle, Knee and Pulse width	161 161 171 –	161 161 – 185	161 161 171 –	161 161 171 –	161 161 171 –	161 161 171 –	161 161 171 –	161 161 171 –	161 161 171 –	161 161 – –	161 161 161 –	161 161 161 –
Weight and height history and weight change^IM – tel. respondent*	160 –	160 –	160 –	160 –	160 –	160 –	160 –	160 –	160 –	160 –	160 714	160 714
Bio-electrical impedance** (subsample)	172	–	–	–	–	–	–	–	–	–	–	–
Birth weight	–	–	–	134	134	–	–	–	134	–	–	–
Perceived body shape** – scaled	– –	– –	– –	– –	– –	145 345	145 345	– –	145 345	145 345	– –	– –
DXA (LASA ancillary study) – Hip / lumbar spine scan – Whole body scan	– –	o41 o42	o41 o42	– –	– –	– –	– –	– –	– –	– –	– –	– –

Chronic diseases	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Self-report of chronic diseases^IM – nr. of diseases reported – tel. proxy* – tel. respondent* – longitudinally cleaned	035 235 – – 435	035 235 602 602 435	035 235 602 702 –	035 235 602 702 –	035 235 – – –	035 235 602 702 –	035 235 602 702 –	035 235 602 702 –	035 235 – – –	035 235 – – –	035 235 602 702 –	035 235 602 702 –
GP information	g01	g01	–	g01	g01	g01	–	g01	g01	–	UC	UC
Aortic calcification (lateral radiographs)	–	zo22	zo22	–	–	–	–	–	–	–	–	–
Diabetes mellitus (algorithm)	zdc1	zdc1	zdc1	zdc1	zdc2	zdc1 zdc2	zdc1 zdc2	zdc1 zdc2	zdc3	–	zdc1 zdc2 zdc3	UC
Rheumatoid Arthritis (algorithm)	–	UC	–	–	–	–	–	–	–	–	–	–
Osteoarthritis hip and knee (algorithm)	zoa1	zoa1	zoa1	zoa1	zoa2	zoa1 zoa2	zoa1 zoa2	zoa1 zoa2	zoa3	–	zoa1 zoa2 zoa3	UC
Metabolic syndrome	–	ch02	–	–	–	–	–	–	–	–	–	–
Allostatic Load (algorithm)	–	X	–	–	–	–	–	–	–	–	–	–
Cardiovascular diseases (algorithm)	zh01	zh01	zh01	–	–	–	–	–	–	–	–	–
Parkinson: early P. related signs**	–	–	–	–	–	–	–	–	096	096	–	–
Decubitus (bedsores)	116 159	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –
Hyperthyroidism**	–	182	182	–	–	–	–	–	–	–	–	–
Back pain	–	182	182	182	–	–	–	–	–	–	–	–
Bedridden	–	182	182	–	–	182	182	182	182	–	–	–

Fertility	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Fertility (women)	119	181¹	–	–	181	–	–	–	181	181	–	–

Falling	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Falls – tel. proxy* – tel. respondent* – Falls last year	– – –	605 605 187	605 705 187	– – –	– – –	– – –	– – –	– – –	– – 187	– – 187	– – –	– – 187
Falls: circumstances and consequences	–	–	187	–	–	–	–	–	–	–	–	–
Falls: environmental conditions (home)**	–	180	180	–	–	–	–	–	–	–	–	–
Falls: fear of falling (FES: Falls Efficacy Scale)	–	183	183	–	–	–	–	–	–	–	–	–
Falls: prevention of fall accidents (LASA ancillary study)	–	–	X	–	–	–	–	–	–	–	–	–
Falls: 3y prospective fall calendar (LASA ancillary study)	–	X	–	–	–	–	–	–	–	–	–	–
Falls: 1y prospective fall calendar (LASA ancillary study)	–	–	–	–	–	–	X	–	–	–	–	–
Dizziness^IM	–	187	187	–	187	187	187	187	187	–	187	187
Adjustments and walking aids**	–	–	187	187	187	187	187	187	187	–	–	–
Foot problems	–	185	185	185	–	185	–	–	–	–	–	–

Fractures	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Fractures – total waves b-f – per wave – tel. proxy* – tel. respondent*	zo13 – – –	zo13 186 605 605	zo13 186 605 705	zo13 186 605 705	zo13 186 – –	zo13 186 605 705	186 605 705	186 605 705	186 – –	186 – –	186 605 705	186 605 705
Vertebral deformities	–	zo22	zo22	–	–	–	–	–	–	–	–	–
Quantitative ultrasound of bone	–	o31	–	–	–	–	o31	–	–	–	–	–

Frailty	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Various definitions (e.g., frailty phenotype, frailty index)	X	X	X	X	X	X	X	X	X	X	X	X

Lifestyle	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Alcohol use^IM – scaled	153 353	153 353	153 353	153 353	153 353	153 353	153 353	153 353	153 353	153 353	153 353	153 353
Diet and food consumption Lifestyle study (LASA ancillary study) Nutrition and food-related behaviour (LASA ancillary study) with subtopics: – Eating patterns – Weight(loss) and appetite – Mindful eating – Meals and snack – Interoceptive awareness of hunger and satiety – Alexithymia – Binge eating – Eating styles – Problems food intake – Use of amenities – Food products for older adults – Dietary recommendations – Sustainable behaviour – Change in sleep and change in appetite	118 – –	118 184 –	118 184 –	– – –	– – –	– – X	– – –	118 – –	– – –	– – –	118 – –	118 – –
MicMac study (LASA ancillary study)											X
Oral health	–	–	–	–	–	X²	–	–	–	–	126	126
Physical activity ^IM	046	046	046	046	046	046	046	046	046	046	046	046
Daily Physical Activity**	–	–	–	–	–	–	–	–	–	–	–	162
Early life physical activity	–	246	–	–	–	–	–	–	–	–	–	–
Perceived physical activity (LIVAS) – scaled	114 314	114 314	114 314	114 314	114 314	114 314	– –	– –	– –	– –	– –	– –
Accelerometry (LASA ancillary studies) – subsample (St. 1) – subsample (St. 2) – subsample (St. 3) – subsample (St. 4)	– – – –	– – – –	– – – –	– – – –	– – – –	X² – – –	– X – –	– – X³ –	– – – –	– – – –	– – – X	– – – –
Sedentary behavior – scaled – scaled	– – –	– – –	– – –	– – –	– – –	– – –	101 301 501	101 301 501	101 301 501	101 301 501	101 301 501	101 301 501
Smoking^IM	154	154	154	154	154	154	154	154	154	154	154	154

Medication/ supplements	B	C	D	E	2B	F	G	H	3B	MB	I4	J	K
Medication and food supplement use⁴ – types of medication	152 352	152 352	152 352	152 352	152 352	152 352	152 352	152 352	152 352	152 352	152 352	152 352
Food supplement use⁴ – Vitamin D use included	– –	– –	– –	– –	– –	– –	– –	– –	– –	– –	174 374	174 374

Pain	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Subjective pain^IM – scaled	115 315	115 315	115 315	115 315	115 315	115 315	115 315	115 315	115 315	115 315	115 315	115 315
Dealing with pain**	–	–	–	188	–	–	–	–	–	–	–
Pain drawing	–	–	–	188	–	–	–	–	–	–	–

Perception: Vision	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Vision (self-report)^IM – total scores – tel. proxy* – tel. respondent*	031 231 – –	031 231 604 604	031 231 604 704	031 231 604 704	031 231 – –	031 231 604 704	031 231 604 704	031 231 604 704	031 231 – –	031 231 – –	031 231 604 704	031 231 604 704
Visual acuity test – Vision-related quality of life	– –	– –	– –	191 192	– –	191 192	191 192	191 192	191 –	– –	– –	– –
Vision: contrast sensitivity	157	157	157	157	157	157	–	–	–	–	–	–

Perception: Hearing	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Hearing (self-report)^IM – total scores – tel. proxy* – tel. respondent*	031 231 – –	031 231 604 604	031 231 604 704	031 231 604 704	031 231 – –	031 231 604 704	031 231 604 704	031 231 604 704	031 231 – –	031 231 – –	031 231 604 704	031 231 604 704
Hearing: Speech in Noise Test (SNT) Hearing: SNT questions	– –	– –	– –	193 194	– –	193 194	193 194	– –	– –	– –	193 194	– –

Perception: smell	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Olfactory function	–	–	–	–	–	–	–	–	S00 S01 S02	S00 S01 S02	–	–

Physical functioning	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
Functional limitations (ADL)^IM – constructed – tel. proxy* – tel. respondent* Use of assistive devices or assistance Limitations in joint mobility Functional limitations partner (ADL)	030 230 – – 030 – –	030 230 603 603 030 183 –	030 230 603 703 030 183 –	030 230 603 703 030 183 139	030 230 – – 030 – –	030 230 603 703 030 – 139	030 230 603 703 030 – 139	030 230 603 703 030 – 139	030 230 – – 030 – 139	030 230 – – 030 – –	030 230 603 703 030 – 139	030 230 603 703 030 – 139
Global Activity Limitations** – tel. respondent*	033 –	033 603	033 703	033 703	033 –	033 703	033 703	033 703	033 –	– –	033 703	033 703
Physical performance	034	034	034	034	034	034	034	034	034	034	034	034
Pulmonary function test – Peak Flow – Spirometry (post bronchodilator)	158 –	158 –	158 –	158 –	– –	– –	158 –	158 –	– 168	– –	– –	– –
Grip strength	–	161	161	161	161	161	161	161	161	161	161	161

Quality of life	B	C	D	E	2B	F	G	H	3B	MB	I	J	K
EuroQol – scaled	– –	– –	– –	135 335	– –	135 335	135 335	135 335	135 335	– –	135 335	– –
Qualeffo-41 – (non)response – Qualeffo scores – scaled	– – –	– – –	– – –	o80 o81 o82	– – –	– – –	– – –	– – –	– – –	– – –	– – –	– – –
SF-12 Health Survey – scaled – scaled (Am.)	– – –	– – –	133 333 533	133 333 533	– – –	133 333 533	133 333 533	133 333 533	133 333 533	– – –	133 333 533	133 333 533
WHO Quality of Life**	–	–	–	–	–	–	–	–	–	–	133	133
Self-rated health – GHPQ – GHPQ: scaled – tel. proxy* – tel. respondent*	036 113 313 – –	036 113 313 602 602	036 113 313 602 702	036 113 313 602 702	036 113 313 – –	036 113 313 602 702	036 113 313 602 702	036 113 313 602 702	036 113 313 – –	036 – – –	036 – – 602 702	036 – – 602 702

LASA-wave	B	C	D	E	2B	F	G	H	3B	MB	I	J	K